The Enterprise Value as of November 2025 (TTM) for Regulus Therapeutics Inc. (RGLS) is 516.89M

According to Regulus Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 516.89M. This represents a change of 553.06% compared to the average of 79.15M of the last 4 quarters.

Regulus Therapeutics Inc. (RGLS) Historical Enterprise Value (quarterly & annually)

How has RGLS Enterprise Value performed in the past?

The mean historical Enterprise Value of Regulus Therapeutics Inc. over the last ten years is 56.82M. The current 516.89M Enterprise Value has changed 90.88% with respect to the historical average. Over the past ten years (40 quarters), RGLS's Enterprise Value was at its highest in in the June 2015 quarter at 420.39M. The Enterprise Value was at its lowest in in the December 2021 quarter at -19084068.80.

Regulus Therapeutics Inc. (RGLS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Regulus Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Regulus Therapeutics Inc. (RGLS) Average Enterprise Value

How has RGLS Enterprise Value performed in the past?

The current Enterprise Value of Regulus Therapeutics Inc. (RGLS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Regulus Therapeutics Inc. (RGLS) Enterprise Value vs. Peers

How is RGLS’s Enterprise Value compared to its peers?

Regulus Therapeutics Inc.’s Enterprise Value is greater than Sage Therapeutics, Inc. (488.88M), greater than Invivyd, Inc. (215.02M), greater than Exscientia plc (374.85M), less than ARS Pharmaceuticals, Inc. (916.05M), less than Apollo Endosurgery, Inc. (579.78M), greater than Niagen Bioscience Inc (465.30M), greater than iTeos Therapeutics, Inc. (245.99M), greater than Sinovac Biotech Ltd. (-506209271.00), greater than Accolade, Inc. (418.16M), greater than G1 Therapeutics, Inc. (402.64M),

Build a custom stock screener for Regulus Therapeutics Inc. (RGLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regulus Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regulus Therapeutics Inc. (RGLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regulus Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.